Distributed by:



 ID SOLUTIONS, a French company,  offers  an innovative,  reliable  and  standardized tool for research and development  tool in oncology diagnosis on  circulating cell-free  DNA from  liquid biopsies  and  tumor DNA  from  solid biopsies . The  IDENTIFY kits allow to detect multiplexed mutation panels using a fully validated, specific and sensitive digital PCR (DPCR)  with the Stilla platform.  

Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next generation genetic tests by providing a groundbreaking and flexible digital PCR (dPCR) solution. 

Through this partnership, the two French companies aim to offer standard operating procedures,  diagnostic  and  theranostic tools with high sensitivity to meet current clinical needs and requirements in  oncology .